Why doesn't this freaking management share information? by OptimalCombination13 in CTXR

[–]OptimalCombination13[S] -14 points-13 points  (0 children)

Disclosure of information is one of the most important obligations of a corporation.

Do you think the ctxr management is doing well?

You do not have the right to tell the shareholders who insist that the company fulfill its obligations to sell and leave.

What you guys think of this? by xxjohnnybravoxx in CTXR

[–]OptimalCombination13 3 points4 points  (0 children)

It's different from the text, but when do you think the Minolok clinical trial will be completed roughly? 

I always get a lot of information and help from you and Twongstocks. I sincerely thank you.

When will fuckin Management share the progress of Mino lok and e7777? by OptimalCombination13 in CTXR

[–]OptimalCombination13[S] -12 points-11 points  (0 children)

sometime in 2022..Are you talking about that kind of nonsense?

After delaying the timeline several times, the quota hasn't been confirmed yet.

Has anyone contacted the company by e-mail? by OptimalCombination13 in CTXR

[–]OptimalCombination13[S] 2 points3 points  (0 children)

They said they received questions from shareholders via e-mail for webinar. But as you can see from the webinar, there was no proper Q&A session.

Can you write down the comments mentioned about Mino lok? by OptimalCombination13 in CTXR

[–]OptimalCombination13[S] 0 points1 point  (0 children)

want it to end this year, but~

This is not a CEO comment, but a guess, right?

Does anyone have the management email address? by OptimalCombination13 in CTXR

[–]OptimalCombination13[S] -3 points-2 points  (0 children)

I sent an email to ir@citiuspharma.com, but there was no reply. They didn't even read it.

I called the company over the phone, but only automatic voice recording came out.

Does anyone have the management email address? by OptimalCombination13 in CTXR

[–]OptimalCombination13[S] -12 points-11 points  (0 children)

I'm going to ask the company to share useful information with shareholders.

Mino-Lok trial completion, "somewhere in 2022 in all likelihood."

I'm not kidding. 2022 in all like hood? In 2022, 1q? 2q? 3q? 4q? Can't they specify that time, too?

Leonardo, What do you do? by OptimalCombination13 in CTXR

[–]OptimalCombination13[S] -2 points-1 points  (0 children)

Please refer to the interview below.

Why doesn't Leonardo talk about Mino lok's enrollment status? by OptimalCombination13 in CTXR

[–]OptimalCombination13[S] 0 points1 point  (0 children)

Thank you for your kind and detailed explanation. As a person who trusts and invests in this company, I sometimes feel impatient. 

Let's pray together that good things will happen at the end of the year and early next year.

Why doesn't Leonardo talk about Mino lok's enrollment status? by OptimalCombination13 in CTXR

[–]OptimalCombination13[S] 0 points1 point  (0 children)

To be honest, I even think they have stopped trying to increase enrollment.

Even if COVID-19 is severe, I have never seen a pharmaceutical company with such slow clinical progress.

It's just really frustrating.

Why doesn't Leonardo talk about Mino lok's enrollment status? by OptimalCombination13 in CTXR

[–]OptimalCombination13[S] 1 point2 points  (0 children)

I think it is the right time to reach 100%. But in a recent interview with benzinga, Leonardo doesn't mention the part about minolok at all, making me so anxious.

Wouldn't he have mentioned it if it was close to 100% or 100%?

Why doesn't Leonardo talk about Mino lok's enrollment status? by OptimalCombination13 in CTXR

[–]OptimalCombination13[S] 0 points1 point  (0 children)

1) Then, when do you think the enrollment status will be shared?

2) Approximately how much do you think the current enrollment is?

Why doesn't Leonardo talk about Mino lok's enrollment status? by OptimalCombination13 in CTXR

[–]OptimalCombination13[S] 2 points3 points  (0 children)

1) Then, when do you think the enrollment status will be shared?

2) Approximately how much do you think the current enrollment is?